Pooja Hingorani

6PUBLICATIONS
68CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group.

Katherine A Janeway, Alexander J Chou, Allen Buxton

|Sep 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.

Daniel Morgensztern, Neal Ready, Melissa L Johnson

|Jun 03, 2022
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium.

Pooja Hingorani, Wendong Zhang, Zhongting Zhang

|Mar 21, 2022
Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma.

Yifei Wang, Xiangjun Tian, Wendong Zhang

|Jan 25, 2021
Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group.

Michael D Kinnaman, Chong Zhu, Daniel A Weiser

|Jan 21, 2021
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.

Leo Mascarenhas, Chitose Ogawa, Theodore W Laetsch

Pageof 1

Frequent Collaborators

4 joint publications

Richard Gorlick

3 joint publications

Jonathan Gill

3 joint publications

Michael Roth

2 joint publications

Raushan T Kurmasheva